Compare AMRC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRC | PRGO |
|---|---|---|
| Founded | 2000 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2010 | 1991 |
| Metric | AMRC | PRGO |
|---|---|---|
| Price | $29.82 | $14.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $33.22 | $22.00 |
| AVG Volume (30 Days) | 446.5K | ★ 4.3M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.19% |
| EPS Growth | ★ 18.87 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | $1,883,767,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $9.83 | N/A |
| Revenue Next Year | $9.83 | N/A |
| P/E Ratio | $25.98 | ★ N/A |
| Revenue Growth | ★ 12.22 | N/A |
| 52 Week Low | $8.49 | $12.17 |
| 52 Week High | $44.93 | $30.93 |
| Indicator | AMRC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 61.05 |
| Support Level | $28.72 | $13.78 |
| Resistance Level | $31.12 | $14.07 |
| Average True Range (ATR) | 1.16 | 0.40 |
| MACD | 0.18 | 0.25 |
| Stochastic Oscillator | 49.38 | 92.49 |
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.